BeautyRival – Beiersdorf AG shares stayed firm on Thursday, trading at €96.34, up 0.2 percent. This came right after the company cut its sales growth forecast for 2025. The German beauty group, known for Nivea, La Prairie, and Chantecaille, now expects 2.5 percent organic growth, down from the previous 3 percent target. The change reflects a clear slowdown in the global skin care market, especially in emerging regions.
CEO Vincent Warnery said that growth in the skin care sector continued to weaken during the third quarter. He highlighted that demand dropped sharply in developing countries. Still, Beiersdorf plans to stay focused on innovation and resilience. The company’s cautious tone mirrors broader market conditions, as many beauty brands are facing slower consumer spending and rising costs worldwide.
“Read More : The Prada Group Reaches €4 Billion: A Testament to Strategy and Strength”
In the third quarter ended Sept. 30, Beiersdorf reported €2.35 billion in sales. That was down 0.9 percent on a reported basis but up 1.7 percent like-for-like. Over the first nine months of 2025, sales reached €7.54 billion, showing a 0.1 percent dip reported and a 2 percent rise in comparable terms. Growth came mainly from the Derma division, with strong demand for Eucerin and Aquaphor products helping to offset softer results in other segments.
Beiersdorf continues to count on Nivea, its flagship brand. The company recently introduced its Epicelline ingredient, calling it the biggest Nivea launch ever. Early sales feedback has been positive. By expanding its focus on skin care innovation and strengthening deodorants as a growth pillar, Beiersdorf aims to give Nivea a more solid foundation for the future. This move shows how the group is adapting to changing consumer needs and competitive pressures.
David Hayes, an analyst at Jefferies, noted that Nivea’s growth rose 8 percent in September due to new product launches. However, the brand still faced declines of about 4.5 percent in July and August. Hayes said that Beiersdorf’s “strategic reset” may take time to deliver steady gains. Investors, therefore, should be patient as the company rebuilds momentum across its core categories.
“Read More : Stan Herman’s Graceful Farewell from QVC After 32 Years”
Despite the slowdown, Beiersdorf’s innovation strategy remains its main advantage. The Epicelline launch highlights the company’s focus on scientific research and product differentiation. By expanding into dermatological and premium beauty, Beiersdorf is diversifying its portfolio and reducing risk. These efforts strengthen its resilience against short-term market challenges and set the stage for longer-term growth.
Beiersdorf’s revised guidance shows both caution and confidence. The company acknowledges near-term headwinds but remains committed to innovation and brand strength. Its strong product pipeline, steady leadership, and loyal consumer base position it for future recovery. In beauty, success depends on patience, adaptability, and creativity qualities Beiersdorf continues to demonstrate.
